Gastrointestinal stromal tumor (GIST) in southern Taiwan: A clinicopathologic study of 93 resected cases

Pathology Research and Practice

Volumn 201, Issue 1, 2005, Pages 1-9

  Li, Chien Feng ^a   Chuang, Shih Sung ^a   Lu, Chin Li ^a   Lin, Ching Nan ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

CD117; GIST; Leiomyosarcoma

Indexed keywords

ALPHA ACTIN; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; IMATINIB; PROTEIN S 100; STEM CELL FACTOR RECEPTOR; TAMOXIFEN;

ADULT; AGED; CLINICAL FEATURE; CONTROLLED STUDY; EPITHELIOID CELL; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TRACT; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MESENCHYMOMA; MITOSIS; MIXED TUMOR; MULTIVARIATE ANALYSIS; PREDICTION; PROTEIN EXPRESSION; REVIEW; SEX DIFFERENCE; SMALL INTESTINE TUMOR; SPINDLE CELL; SPINDLE CELL CARCINOMA; STOMACH TUMOR; TAIWAN; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 14644420225     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prp.2004.11.002     Document Type: Article

References (25)

1. J.J. Berman T.J. O'Leary Gastrointestinal stromal tumor workshop Hum. Pathol. 32 2001 578-582
2. E. Buchdunger C.L. Cioffi N. Law D. Stover S. Ohno-Jones B.J. Druker N.B. Lydon Abl protein-tyrosine kinase inhibitor STI-571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors J. Pharmacol. Exp. Ther. 295 2000 139-145
3. E. Buchdunger J. Zimmermann H. Mett T. Meyer M. Muller B.J. Druker N.B. Lydon Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative Cancer Res. 56 1996 100-104
4. J.K. Chan Mesenchymal tumors of the gastrointestinal tract: A paradise for acronyms (STUMP, GIST, GANT, and now GIPACT), implication of c-kit in genesis, and yet another of the many emerging roles of the interstitial cell of Cajal in the pathogenesis of gastrointestinal diseases? Adv. Anat. Pathol. 6 1999 19-40
5. C.L. Corless L. McGreevey A. Haley A. Town M.C. Heinrich KIT mutation are common in incidental gastrointestinal stromal tumors one centimeter or less in size Am. J. Pathol. 160 2002 1567-1572
6. R.P. Dematteo M.C. Heinrich W.M. El-Rifai G. Demetri Clinical management of gastrointestinal stromal tumors: Before and after STI-571 Hum. Pathol. 33 2002 466-477
7. R.P. DeMatteo J.J. Lewis D. Leung S.S. Mudan J.M. Woodruff M.F. Brennan Two hundred gastrointestinal stromal tumors-recurrence patterns and prognostic factors for survival Ann. Surg. 231 2000 51-58
8. C.D. Fletcher J.J. Berman C. Corless F. Gorstein J. Lasota B.J. Longley M. Miettinen T.J. O'Leary H. Remotti B.P. Rubin B. Shmookler L.H. Sobin S.W. Weiss Diagnosis of gastrointestinal stromal tumors: A consensus approach Hum. Pathol. 33 2002 459-465
9. A. Handra-Luca J.F. Flejou G. Molas A. Sauvanet J. Belghiti C. Degott B. Terris Familial multiple gastrointestinal stromal tumours with associated abnormalities of the myenteric plexus layer and skeinoid fibers Histopathology 39 2001 359-363
10. T.H. Hu J.W. Lin C.S. Changchien S.Y. Liu S.S. Chiou J.H. Chuang Immunohistochemical analyses of gastric stromal tumors in Taiwan J. Formos. Med. Assoc. 102 2003 707-714
11. K. Isozaki B. Terris J. Belghiti S. Schiffmann S. Hirota J.M. Vanderwinden Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumours Am. J. Pathol. 157 2000 1581-1585
12. K. Kontogianni M. Demonakou N. Kavantzas A.Ch. Lazaris K. Lariou C. Vourlakou P. Davaris Prognostic predictors of gastrointestinal stromal tumors: A multi-institutional analysis of 102 patients with definition of a prognostic index EJSO 29 2003 548-556
13. J.D. Licht L.B. Weissmann Antman. Gastrointestinal sarcoma, Semin. Oncol. 15 1988 181-188
14. S.C. Lin M.J. Huang C.Y. Zeng T.I. Wang Z.L. Liu R.K. Shiay Clinical manifestations and prognostic factors in patients with gastrointestinal stromal tumors World J. Gastroenterol. 9 2003 2809-2812
15. M. Miettinen W. El-Rifai H.L. Sobin J. Lasota Evaluation of malignancy and prognosis of gastrointestinal stromal tumor: A review Hum. Pathol. 33 2002 478-483
16. M. Miettinen J. Lasota Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical and molecular genetic features and differential diagnosis Virchows Arch. 438 2001 1-12
17. M. Miettinen M. Sarlomo-Rikala J. Lasota Gastrointestinal stromal tumors: Recent advances in understanding of their biology Hum. Pathol. 30 1999 1213-1218
18. M. Miettinen L.H. Sobin M. Sarlomo-Rikala Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT) Mod. Pathol. 13 2000 1134-1142
19. E.H. Ng R.E. Pollock M.M. Romsdahl Prognostic implications of patterns of failure for gastrointestinal leiomyosarcoma Cancer 69 1992 1334-1341
20. T. Nishida S. Hirota Biological and clinical review of stromal tumors in the gastrointestinal tract Histol. Histopathol. 15 2000 1293-1301
21. M. Sarlomo-Rikala A.J. Kovatich A. Barusevicius M. Miettinen CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34 Mod. Pathol. 11 1998 728-734
22. K. Sircar B.R. Hewlett J.D. Huizinga K. Chorneyko I. Berezin R.H. Riddell Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors Am. J. Surg. Pathol. 23 1999 377-389
23. L. Thomsen T.L. Robinson J.C. Lee L.A. Farraway M.J. Hughes D.W. Andrews J.D. Huizinga Interstitial cells of Cajal generate a rhythmic pacemaker current Nat. Med. 4 1998 848-851
24. T. Tornoczky E. Kover L. Pajor Frequent occurrence of low grade cases among metastatic gastrointestinal stromal tumours J. Clin. Pathol. 56 2003 363-367
25. X. Wang I. Mori W. Tang H. Utsunomiya M. Nakamura Y. Nakamura G. Zhou K. Kakudo Gastrointestinal stromal tumors: Clinicopathological study of Chinese cases Pathol. Int. 51 2001 701-706